Multi-Cancer Blood Test Could Significantly Reduce Late-Stage Diagnoses
A simulation model shows that annual liquid biopsy screening would increase early-stage cancer detection by up to 30% while cutting stage IV diagnoses by 45%.
Read MorePosted by CLP Edit Staff | Nov 10, 2025 | Cancer |
A simulation model shows that annual liquid biopsy screening would increase early-stage cancer detection by up to 30% while cutting stage IV diagnoses by 45%.
Read MorePosted by CLP Edit Staff | Nov 7, 2025 | Lung Cancer |
University of Texas at Dallas researchers combine electrochemical biosensors with AI to identify volatile organic compounds linked to thoracic cancers.
Read MorePosted by CLP Edit Staff | Oct 31, 2025 | Cancer |
A new study demonstrates the capability of a blood test in detecting ovarian cancer up to three years prior to diagnosis in prospectively collected samples.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Breast |
The agreement focuses on clinical validation of ESR1 mutation detection assay for advanced breast cancer testing using ddPCR technology.
Read MorePosted by CLP Edit Staff | Oct 24, 2025 | Cancer |
PATHFINDER 2 study results indicate more than half of cancers detected by Galleri test were found in early stages, with three-quarters having no current screening options.
Read More